![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3938|8|1|81-88
ISSN: 1574-8847
Source: Current Clinical Pharmacology, Vol.8, Iss.1, 2013-02, pp. : 81-88
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Camacho Luis Olson Jon Tong William Young Charles Spriggs David Malkin Mark
Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Wilding George King David Tutsch Kendra Pomplun Marcia Feierabend Chris Alberti Dona Arzoomanian Rhoda
Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors
By Hensley Martee Dizon Don Derosa Felicia Venkatraman Ennapadam Sabbatini Paul Chi Dennis Dupont Jakob Colevas A. Spriggs David Aghajanian Carol
Investigational New Drugs, Vol. 25, Iss. 4, 2007-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Kalmadi S. Davis M. Dowlati A. O’Keefe S. Cline-Burkhardt M. Pelley R. Borden E. Dreicer R. Bukowski R. Mekhail T.
Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. :